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Abstract
Background:  Lymphoid tissues constitute basic structures where specific immune responses take
place.  This  leads  to  the  development  of  germinal  centres  (GCs),  migration  of  cells  and  the
generation of memory cells. Here, we have compared human tumour reactive lymph nodes and
tonsils with control lymph nodes.
Results:  The study by flow cytometry shows that in control lymph nodes the majority of cells
were  naive  T-lymphocytes  (CD45RA+/CD7+).  In  reactive  nodes,  although  the  percentage  of
CD45RO+ T cells remains constant, there is an increase in the number of B-lymphocytes, and a
reduction in naive T cells. The percentage of cells expressing CD69 was similar in reactive nodes
and in controls. In both cases, we have found two populations of B cells of either CD69- or
CD69dull. Two populations of T cells, which are either negative for CD69 or express it in bright
levels (CD69bright), were also found.
The analysis of tissue sections by confocal microscopy revealed differences between control, tonsils
and tumor reactive lymph nodes. In control lymph nodes, CD19 B cells are surrounded by a unique
layer of CD69bright/CD45RO+ T cells. GCs from tonsils and from tumour reactive nodes are
mainly constituted by CD19 B cells and have four distinct layers. The central zone is composed of
CD69- B cells surrounded by CD69bright/CD45RO+  T  cells.  The  mantle  region  has  basically
CD69dull B-lymphocytes and, finally, there is an outer zone with CD69-/CD45RO+ T cells.
Conclusions:  Human secondary lymphoid organs react with an increase in the proportion of B
lymphocytes and a decrease in the number of CD45RA+ T cells (naive). In tonsils, this is due to
chronic pathogen stimulation, whereas in lymph nodes draining head and neck carcinomas the
reaction is prompted by surrounded tumors. During this process, secondary lymphoid organs
develop secondary follicles with a special organization of T and B cells in consecutive layers, that
are described here by confocal microscopy. This pattern of cellular distribution may suggest a
model of cell migration into the secondary lymphoid follicles.
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Background
Efficient interactions between T, B and antigen-present-
ing cells in T-dependent immune responses take place at
the secondary lymphoid organs [1–3]. T cells are located
mainly in the paracortical zone, which includes the inter-
follicular regions. B cells are placed in small primary fol-
licles in the cortex, which become secondary follicles or
germinal centres (GCs) after antigenic stimulation [4].
Most recent studies of the GC reaction focused either on
B cells, centroblasts and centrocytes, or on follicular den-
tritic cells. It is known that T cells have a crucial role in
the development of the GC reaction, mediated by both
cellular contacts and humoral factors (interleukins). GC
T cells express CD40L (CD154) [5,6], a molecule which
allows the interactions with CD40+ B-lymphocytes. High
affinity B cells, selected by antigen retained in the surface
of follicular dendritic cells (FDCs) [1,7], become antibody
producing plasma cells or memory B cells. This distinc-
tion is determined by the signals of the CD40/CD40L in-
teraction and by the type of interleukins secreted by T
cells [5,6,8,9]. Non-selected B cells, however, die by ap-
optosis [2,8,10,11,12]. The activation and generation of
memory T cells in the secondary follicles of lymphoid tis-
sues remain unclear, although much is known about
these processes in B cells. Some authors have shown
that, in mice, T cells migrating to follicles are also able to
proliferate the developing GC [13,14]. During the GC re-
action, T cells become concentrated both, at and near the
junction of the follicular mantle with the light zone.
Some cells remain there after the end of the GC reaction
[13].
The origin, migration and role of intra-GC T cells in hu-
man follicles is not accurately known, as it is not possible
to study the kinetic of the GC reaction in humans. This
study compares control lymph nodes with human tonsils
and tumour reactive lymph nodes from patients with
head and neck's carcinomas.
The identification and distribution of cells in these nodes
has been achieved through the study of several markers
and other membrane antigens. The markers used were
CD69, which is a very early activation antigen, CD45RA,
a marker mostly associated to virgin cells and CD45RO,
a marker associated to memory cells. In addition to the
differences between control and reactive lymph nodes,
an interesting distribution of the B and T cells in several
layers was found, when tissue sections were performed.
These results suggest a speculative model of the cellular
traffic into the GC, giving a crucial role to the T cells in
the regulation of the GC reaction.
Results
Decrease of CD45RA+ T cells in tonsils and tumour reac-
tive lymph nodes
Lymphoid subpopulations from human control lymph
nodes, tonsils and tumour reactive lymph nodes have
been compared. Flow cytometry was used to analyse a to-
tal of 28 control lymph nodes, 9 tonsils and 65 head and
neck tumour reactive lymph nodes. In all cases several
markers were used (Table 1). These included markers re-
lated to specific T or B cells, others, like CD69, to the ac-
tivation level and, finally, CD45RA naive or CD45RO
memory, which are associated with the state of matura-
tion.
The results show that T cells are the main population in
all groups analysed. However, there is a decrease in the
number of T cells, both CD4 and CD8 lymphocytes, in tu-
mour reactive lymph nodes and in tonsils, compared to
controls (Table 1). To study the expression of the mole-
cule CD45, double immunofluorescence was used. Both
the CD45RA isoform, associated to the naive phenotype,
and the CD45RO-related to the memory phenotype [15–
18] were analysed. This revealed a decrease in the per-
centage of CD7+/CD45RA+ in tonsils and in tumour re-
active lymph nodes compared to controls (Figure 1). No
Figure 1
Two color analysis of lymphocytes from human con-
trol lymph nodes (A), tonsils (B) and reactive lymph
nodes to head and neck carcinoma (C). Cells were
stained  with  anti-CD45RA-FITC  and  anti-CD7-PE
monoclonal antibodies.BMC Immunology (2001) 2:2 http://www.biomedcentral.com/1471-2172/2/2
percentual change was detected in the expression of
CD45RO within tonsils and nodes. However, an increase
in the percentage of B cells in tonsils and in tumour reac-
tive lymph nodes, was observed in comparison with con-
trol lymph nodes.
The analysis of CD69, described as an early activation
marker [19,20], indicates that it is expressed in a fraction
of lymphocytes in all lymph nodes analysed (Table 1). Al-
though slightly higher in tonsil B cells, there are no sig-
nificant differences in the expression of CD69 between
reactive and control lymph nodes. The differences in the
intensity of this marker are worth noting. CD69bright is
expressed in a fraction of T cells, but B cells are mainly
CD69- or dull (Figure 2).
Histological distribution of lymphoid subpopulations in 
control lymph nodes, tonsils and head and neck tumour re-
active lymph nodes
As described in Materials and Methods tissue sections
were analysed by confocal microscopy. Subpopulations
of cells with specific monoclonal antibodies against dif-
ferent membrane molecules were identified. Nuclear
staining was performed with 7-AAD (in blue). As was ex-
pected, in control lymph nodes there are mainly primary
follicles constituted by accumulations of B-lymphocytes
surrounded by T cells. However, GCs appear in both, tu-
mour reactive lymph nodes and tonsils. By confocal mi-
croscopy, B cells in control lymph nodes were mainly
CD19dull. This contrasted with GC B-lymphocytes from
tonsils and tumour reactive lymph nodes that expressed
on their membrane higher levels of the CD19 antigen
(Figure 3). Although other causes cannot be completely
rule out, the variations found in the fluorescence intensi-
ty of the marker CD19 could be due to the larger size of
the GC-B cells
In tonsils and in tumour reactive lymph nodes, second-
ary follicles or GCs showed a particular lymphocyte dis-
tribution in four layers. From the internal to the outer
part of the GC, layers of B / T / B and, finally, again T-
lymphocytes can be seen. Although some CD7+ T cells
are also present (Figure 3), the internal layer is formed
mainly by CD19+ B cells. It is possible to see a thin layer
of CD7+ T cells as a crown of cells, surrounding these B
cells (C in Figure 3). The third layer, external to these T
cells, is constituted by small B-lymphocytes, which form
the follicular mantle region. Among these follicular man-
tle B cells there are some CD7+ T cells located in a radial
disposition. The final layer is formed by CD7 + T-lym-
phocytes that spread to the interfollicular zones. Despite
the lower number of secondary follicles found in tumour
reactive lymph nodes as compared to those in tonsils,
both showed the same distribution in layers of T and B
cells (Figure 3).
The tissue location of cells expressing the CD69 antigen
(in red) together with two T cell markers, CD3 or
CD45RO (both in green), are shown in Figures 4 and 5
respectively. The images obtained from tonsils and tu-
mour reactive lymph nodes reveal that the T cell layer in
the GC located under the mantle (C in Figures 4 and 5),
is CD3+/CD45RO+/CD69bright. However, follicular
mantle B cells are weakly positive for CD69 staining
(CD69dull). Scattered T-lymphocytes CD3+/CD45RO+
with a variable expression of CD69 antigen appear in the
mantle zone: cells near the T cell layer (region C in Fig-
ures 4 and 5) are CD69dull, while those close to the outer
zone of the mantle are CD69 - (fig 5). Very few CD69+
cells were found in the interfollicular T zones.
In control lymph nodes it is possible to find some CD3+/
CD45RO+/CD69+ cells in a discrete and defined area
around B cells in the primary follicle. Follicular B cells
appear weakly positive to CD69, similar to what is found
in the secondary follicle mantle B cells.
Figure 2
Expression of antigen CD69 in human lymphocytes
from control lymph nodes (A), tonsils (B) and reac-
tive lymph nodes to head and neck carcinoma (C).
Cells  were  stained  with  anti-CD3-FITC  and  anti-
CD69-PE monoclonal antibodies.BMC Immunology (2001) 2:2 http://www.biomedcentral.com/1471-2172/2/2
Figure 3
Distribution of T (CD7+) and B cells (CD19+) in frozen sections from human control lymph node, tonsil and
reactive lymph node to head and neck carcinoma. Sections were stained with anti-CD7- PE and anti-CD19-FITC mon-
oclonal antibodies and with 7 AAD and analyzed by confocal microscopy. F: primary follicle; GC: germinal center; M: mantle of
B cells; C: centrogerminal layer of T cells.BMC Immunology (2001) 2:2 http://www.biomedcentral.com/1471-2172/2/2
Figure 4
Comparison of the distribution of activated and memory T cells in frozen sections from human control lymph
node and tonsil. Sections were stained with 7 AAD, anti-CD69-PE and with anti-CD3-FITC monoclonal antibodies. F: pri-
mary follicle; GC: germinal centre; M: mantle of B cells; C: centrogerminal layer of T cells.BMC Immunology (2001) 2:2 http://www.biomedcentral.com/1471-2172/2/2
Figure 5
Distribution of activated and memory T cells in frozen sections from human reactive lymph node to head and
neck carcinoma. Sections were stained with 7 AAD, anti-CD69-PE and with anti-CD45RO-FITC monoclonal antibodies. F:
primary follicle; GC: germinal centre; M: mantle of B cells; C: centrogerminal layer of T cells.BMC Immunology (2001) 2:2 http://www.biomedcentral.com/1471-2172/2/2
Discussion
The quantitative and histological changes, at the cellular
level, that take place in human secondary lymphoid tis-
sues are described in this paper. These result from either
chronic stimulation by pathogens in tonsils, or by tu-
mour stimulation in the draining lymph nodes of human
head and neck squamous carcinomas. An increase in the
percentage of B-lymphocytes in these organs compared
to control lymph nodes, due to the generation of GCs af-
ter antigen stimulation, was observed by flow cytometry.
In tissue sections, the phenotype and morphology of the
primary follicle B cells, in control lymph nodes, were
seen to be similar to the secondary follicle mantle B cells
in tumor reactive lymph nodes or in tonsils. Several au-
thors consider that after the stimulation, during the im-
mune response, the human B cells placed outside the
follicles, in the T cell areas, migrate to the region of B
cells and FDCs that form the primary follicle [1,4,21,22].
The stimulated B cells proliferate giving rise to centrob-
lasts, which push the naive B cells to the periphery of the
GC, thus generating the follicular mantle [2,4,22].
Regarding the T cell population, the most significant
data is the decrease of naive T-lymphocytes (CD45RA+)
in reactive lymph nodes. Previous studies in other spe-
cies have demonstrated that naive circulating lym-
phocytes (L-selectin+) penetrate in the lymph node by
the blood vessels and go out by efferent lymphatics
[15,16,23]. This decrease in naive T cells could be due to
a change of phenotype (from CD45RA+ naive T-lym-
phocytes to CD45RO+memory cells) or to the dilution of
this population due to the higher number of reactive
lymph node cells. In addition, it has been described that
memory cells are retained more often in the sites were
antigen is present [15,24]. In fact, our studies in tissue
sections show an increase of CD45RO+ cells compared to
control lymph nodes. These CD45RO+ cells are located
mainly in two zones: 1) between the follicular mantle and
the light zone of the GC and 2) surrounding the second-
ary follicle.
Surprisingly, in the three types of tissues studied, CD69
antigen was only highly expressed in a T-lymphocyte
fraction, while B-lymphocytes showed either a negative
or a low expression. CD69 has been reported to be an
early activation marker [19,20], therefore its presence
was expected only in reactive lymph nodes and tonsils
but not in controls. The study by confocal microscopy
confirmed the flow cytometry results. CD69dull B cell
population is constituted by cells that form the primary
follicles in control lymph nodes and also the GC follicular
mantle in reactive lymph nodes and tonsils. It has been
described that neither primary follicle B cells nor follicu-
lar mantle B cells proliferate during the immune re-
sponse [6]. This could imply that both have the same
origin. The small increase in the CD69 expression found
in tonsils, by flow cytometry analysis, is probably due to
Table 1: Lymphocyte subpopulations from control lymph nodes, tonsils and reactive lymph nodes to head and neck carcinoma
Control lymph Reactive lymph nodes to lead
nodes Tonsils and neck carcinoma
ANTIGEN N Mean ± NM e a n  ± Pa) (Tonsil N Pa)(reactive
SD SD Vs control) Mean ±  SD Vs control)
CD7 27 68 ±  10 9 48 ±  11 0.0002 62 62 ±  11 0.01
CD19 26 24 ±  10 9 40 ±  15 0.004 63 30 ±  11 0.05
CD4 26 58 ±  10 9 42 ±  10 0.0005 65 56 ±  12 NS
CD8 27 12 ±  5 9 8 ±  1 0.002 65 9 ±  4 0.03
CD45RA 28 63 ±  9 9 54 ±  17 NS 64 58 ±  12 NS
CD45RO 28 29 ±  8 9 31 ±  9 NS 63 33 ±  10 NS
CD7/
CD45RA
25 37 ±  14 9 16 ±  4 0.0004 60 29 ±  10 0.004
CD7/
CD45RO
26 24 ±  8 9 27 ±  9 NS 60 28 ±  8 NS
CD69 8 14 ±  12 9 29 ±  10 0.02 14 23 ±  10 NS
CD3/CD69 7 12 ±  11 9 21 ±  10 NS 14 19 ±  8 NS
a) P < 0.05 by Kruskal-Wallis test considered significant. NS means no significant.BMC Immunology (2001) 2:2 http://www.biomedcentral.com/1471-2172/2/2
the greater number of GCs in this tissue, which obviously
provokes an increase in the number of mantle cells.
CD69bright T-lymphocytes surround B-lymphocytes in
primary follicles and are in close contact with the inter-
nal part of the CD19/CD69dull mantle B cells in the sec-
ondary follicles. This suggests an unknown functional
association between these CD69 positive T-lymphocytes
and mantle B cells. As the CD69 ligand is still unknown,
it is possible to speculate that this molecule could be in-
volved in interactions between these two lymphocyte
subpopulations.
By confocal microscopy, GCs in tonsils and in tumour re-
active lymph nodes can be seen with a distribution of
cells in several layers: a CD19bright B cell zone, a
CD69bright/CD45RO+ intra-GC T cell layer, a follicular
mantle B cell layer and an external T cell zone. A group of
T-lymphocytes CD3+/CD69bright/CD45RO+ is organized
between the light zone of the GC and the follicular man-
tle, as a crown of cells. Their phenotype supports find-
ings reported by other authors in mice [5]. Moreover, it
is similar to the narrow T cell layer that surrounds the
primary follicles in human control lymph nodes (Figure
4). It seems possible that these T cells (CD3+/
CD69bright/CD45RO+), already observed in the primary
follicle, could give place to the GC T cells when an im-
mune response is initiated.
This distribution in a four layer-structure of different
lymphoid populations (B / T / B / T cells), indicates a
very organized structure. From our results and with data
from several authors, a speculative model of migration
and activation of lymphocytes in the GCs is suggested
(Figure 6). Some authors [4,25] support the hypothesis
that T-B interaction takes place in the area that sur-
rounds the primary follicle and that, later, stimulated B
and T cells migrate to the follicle, where they proliferate
[13], forming the GCs. In the inner part of the GC, these
CD69bright/CD45RO+ T-lymphocytes could be generated
by T-B cellular interaction, migrating to the marginal
zone of GC, in close contact with the mantle (Figures 4
and 5). In this model, it is proposed that proliferating
memory T cells could continuously be exported to the
CD45RO+ layer that surrounds the secondary follicle and
that follicular mantle B-lymphocytes could participate in
this migration. The CD69 molecule might participate in
this process. Moreover, scattered memory T-lym-
phocytes were found among mantle B cells. The expres-
sion of CD69 varies in these T-lymphocytes, it
diminishes moving out from the internal part of the GC
and it is lacking in cells located near to the outside of the
follicle. It is likely that these GC T-lymphocytes could in-
teract with mantle B cells, and also could express all the
necessary molecules to be able to interact with B-lym-
phocytes [6]. Interactions with mantle B cells may pro-
voke an exit of T cells to the mantle outer zone. This may
avoid continuous GC T-lymphocyte generation and ex-
pansion, which would lead to an unregulated or exacer-
bated immune response. T cells would join the
physiological barrier created by mantle B cells and stop
the immune response, keeping a resting memory T-lym-
phocyte store outside the follicle.
To confirm some of these hypotheses, experiments are
currently being carried out in our laboratory. These in-
clude the study of whether the memory T lymphocytes
from the outer layer are progeny of the lymphocytes
placed in the inner layers.
Conclusions
Human control lymph nodes have a higher number of T
lymphocytes than tonsils or tumor reactive lymph nodes.
These are mostly T cells with naive phenotype
(CD45RA+). Histologically, control lymph nodes only
show primary lymph follicles. Tonsils and tumor reactive
lymph nodes display an increase in the number of B cells
and a decrease in the number of CD45RA+ T lym-
phocytes. Studies in tissue sections show the formation
of secondary lymphoid follicles with a very organized
structure constituted by alternative layers of subpopula-
tions of B and T lymphocytes: CD19bright B cell zone,
CD69bright CD45RO+ intra- GC T cell layer, a follicular
mantle B cell layer and an external T cell zone. The char-
acteristics of mantle B cells are nearly identical to the pri-
mary follicle B cells. We propose a hypothetical model of
lymphocyte migration in the GC.
Materials and methods
Tumour reactive lymph nodes
We have analysed 65 lymph nodes from 44 patients suf-
fering from head and neck squamous carcinomas, with
ages ranging between 30 to 65 years. Nodes from pa-
tients treated with radiotherapy or chemotherapy were
not included in this study. Enlarged reactive lymph
nodes were selected randomly from the region draining
the area of the tumour and surgically excised. One to
three nodes were obtained from each patient.
Control lymph nodes
The study of truly non-reactive nodes is limited by ethi-
cal and practical considerations. Therefore, cystic nodes
from patients undergoing surgery for cholelithiasis were
taken. Neck lymph nodes were also taken from patients
suffering from a thyroid pathology. Inflammatory or tu-
moral pathologies were excluded. We consider that these
nodes represent the closest approximation to normality
that can be achieved in a study of this type. Nineteen pa-
tients aged between 25- 65 years were studied.BMC Immunology (2001) 2:2 http://www.biomedcentral.com/1471-2172/2/2
Tonsils
Nine tonsils were obtained from surgical operations on
patients suffering from recurrent tonsillitis. The patients
were between 8 and 38 years of age.
Cell preparations
Single cell suspensions of lymphoid cells were prepared
by pressing each lymph node through a stainless steel
mesh. The suspensions were placed in cold medium (RP-
MI 1640) supplemented with 2% FCS and 0.02% sodium
azide.
Monoclonal Antibody Staining
FITC or PE-conjugated monoclonal antibodies were pur-
chased from Coulter, Immunotech and Boehringer In-
gelheim. Details of the panel antibodies used are given in
Table 2. The staining technique involved direct two-col-
our immunofluorescence. A million cells were incubated
45 min at 4° C with optimal amounts of FITC and PE-con-
jugated mAb, washed twice (RPMI 2% FCS) and resus-
pended in medium. Samples were fixed by adding 200 µ l
of 0.1% paraformaldehyde solution in PBS to the cellular
suspension.
Flow-cytometric Analysis
An ELITE flow cytometer (Coulter Electronics, Hialeah,
FL) equipped with an argon ion laser (488 nm) was used.
Lymphocytes were gated using forward and orthogonal
light scatter, and the percentage of positive cells for each
marker was measured. A minimum of 5,000 cells was
analysed for each sample.
Data Analysis
The lymph nodes were classified as control tonsils or re-
active nodes to head and neck carcinoma. The control
lymph nodes were cystic nodes and neck nodes from pa-
tients with non-inflammatory pathologies. The results
obtained by flow cytometry were statistically analysed
with the SPSS program. The standard error of the mean
Figure 6
Proposed model of T cell migration during the devel-
opment of a secondary follicle. A. primary follicle. The
CD7+/CD45RO+/CD69bright  are  disposed  surrounding  the
primary  follicle.  B.  After  antigenic  challenge  the  CD7+/
CD45RO+/CD69bright cells migrate into the follicle, where
they proliferate. C. The T cells originated into the germinal
centre migrate out of the secondary follicle. The expression
of CD69 diminishes going out from the internal part of the
GC and it is lacking in cells outside of the follicle.
Table 2: Monoclonal antibodies used
Official name Clone Population recognized
CD3 UCHT1 T cell lineage
CD4 T4 Helper/ inducer T cells
CD7 3A1 T cell lineage
CD8 T8 Cytotoxic T cells
CD19 B4 B cells
CD25 1HT44H3 Activated T and B cells
CD45RA ALB 11 B and T cell subset
CD45RO UCHL1 T cell subset
CD69 CH/4 Activated T and B cellsBMC Immunology (2001) 2:2 http://www.biomedcentral.com/1471-2172/2/2
was determined for each group of nodes. The non-para-
metric Kruskal-Wallis test was used to assess the statis-
tical significance. This test was chosen because of the
difficulty to discern the normal distribution of our data
due to the number of samples analyzed.
Tissue sections
Frozen tissue sections of secondary lymphoid organs
were fixed in acetone. The staining technique involved
three-colour direct immunofluorescence. FITC and PE-
conjugated monoclonal antibodies were from Coulter,
Immunotech and Boehringer Ingelheim, and 7-aminoac-
tinomycin D (7AAD) was from Sigma. To avoid unspecif-
ic binding the sections with RPMI+2.5% FCS were
incubated for 30 minutes. The sections were washed
with PBS and incubated 2 hours in a humid chamber in
the dark with enough amounts of antibodies and the
7AAD (1 µ g/ml) to cover the tissue. Samples were
washed twice with PBS and then prepared with Mount-
ing Medium (Inova Diagnostics Inc.). The sections were
maintained at 4° C until analysed.
Histological study with confocal microscopy
Three-colour signals were collected separately on a Bio-
Rad MRC-1024-ES confocal system equipped with a
krypton/argon ion laser (property of C.A.C.T.I., Vigo
University). Photomicrographs were taken from elec-
tronic overlays.
Abbreviations
7AAD, 7- aminoactinomycin D; CD40L, CD40 ligand;
FDC, follicular dendritic cell; GC, germinal center.
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